Compare Organon Pharma Indonesia Tbk. (SCPI) vs Sekar Laut Tbk. (SKLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Sekar Laut Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Sekar Laut Tbk. trades at Rp214 (market cap 1.48T, 1.6K 24h volume). The key difference: Sekar Laut Tbk. is far larger — about 14.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | SKLT | |
|---|---|---|
Market Cap | 104.4B | 1.48T |
Volume | — | 1.6K |
Lot | — | 16 |
Turnover | — | 344.4K |
Average Price | — | 215.25 |
Value | — | 344.4K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Sekar Laut Tbk.
PT. Sekar Laut Tbk (the Company)was established based on the notarial deed No. 120 dated July 19, 1976 of Soetjipto, S.H., public notary in Surabaya.. The Company has been developing and producing tomato sauce, chili sauces, ready to use seasoning, and snack which are marketed under the brand name of “FINNA”. The Company started commercial operations in January 1977.
Read more on SKLT →
